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Abstract
Background: The human immunodeficiency virus type 1(HIV-1) epidemic in Chongqing, China, is increasing
rapidly with the dominant subtype of CRF07_BC over the past 3 years. Since human leukocyte antigen (HLA)
polymorphisms have shown strong association with susceptibility/resistance to HIV-1 infection from individuals
with different ethnic backgrounds, a recent investigation on frequencies of HLA class I and class II alleles in a
Chinese cohort also indicated that similar correlation existed in HIV infected individuals from several provinces
in China, however, such information is unavailable in Chongqing, southwest China.
Methods: In this population-based study, we performed polymerase chain reaction analysis with sequence-
specific oligonucleotide probes (PCR-SSOP) for intermediate-low-resolution HLA typing in a cohort of 549 HIV-
1 infected individuals, another 2475 healthy subjects from the Han nationality in Chongqing, China, were selected
as population control. We compared frequencies of HLA-A, B, DRB1 alleles, haplotypes and genotypes between
the two groups, and analyzed their association with HIV-1 susceptibility or resistance.
Results: The genetic profile of HLA (A, B, DRB1) alleles of HIV-1 infected individuals from Chongqing Han of
China was obtained. Several alleles of HLA-B such as B*46 (P = 0.001, OR = 1.38, 95%CI = 1.13-1.68),
B*1501G(B62) (P = 0.013, OR = 1.42, 95%CI = 1.08-1.88), B*67 (P = 0.022, OR = 2.76, 95%CI = 1.16-6.57), B*37
(P = 0.014, OR = 1.93, 95%CI = 1.14-3.28) and B*52 (P = 0.038, OR = 1.64, 95%CI = 1.03-2.61) were observed
to have association with susceptibility to HIV-1 infection in this population. In addition, the haplotype analysis
revealed that A*11-B*46, A*24-B*54 and A*01-B*37 for 2-locus, and A*11-B*46-DRB1*09, A*02-B*46-DRB1*08,
A*11-B*4001G-DRB1*15, A*02-B*4001G-DRB1*04, A*11-B*46-DRB1*08 and A*02-B*4001G-DRB1*12 for 3-
locus had significantly overrepresented in HIV-1 infected individuals, whereas A*11-B*1502G, A*11-B*1502G-
DRB1*12 and A*33-B*58-DRB1*13 were underrepresented. However, the low-resolution homozygosity of HLA-
A, B, DRB1 loci and HLA-Bw4/Bw6 genotypes did not differ significantly between the two groups.
Conclusion: These results may contribute to the database of HLA profiles in HIV-1 infected Chinese population,
consequently, the association of certain HLA alleles with susceptibility or resistance to HIV-1 infection would
provide with clues in choosing proper preventive strategies against HIV-1 infection and developing effective HIV-
1 vaccines in Chinese population, especially for those in southwest China.
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Background
The HIV/AIDS epidemic remains a significant global
problem because drug resistances occur so frequently and
no effective preventive vaccine is available. Currently
there are an estimated 33 million people living with HIV/
AIDS worldwide and this number is growing rapidly,
especially in developing countries where approximately
90% of the total patients lives [1]. In Asia, an estimated
4.9 million [3.7 million-6.7 million] people were living
with HIV in 2007, including 440 000 [210 000-1.0 mil-
lion] people who became newly infected in that year.
Approximately 300 000 [250 000-470 000] patients died
from AIDS-related illnesses in 2007 [2]. Chongqing, a
municipal city in southwest China, has a population of
more than 31 million. The first HIV-1 infected case from
Chongqing was reported in 1993, by the end of 2007, up
to 3913 individuals were reported as HIV-1 positive, the
dominant HIV-1 subtype in Chongqing is CRF07_BC
[3,4].
The human major histocompatibility complex (MHC)
gene cluster on the short arm of chromosome 6, contains
the most polymorphic loci in humans, the human leuko-
cyte antigens (HLA) class I and class II genes. The class I
loci, HLA-A, -B, and -C, are involved in cytotoxic T cell-
mediated immunity; the class II loci, HLA-DR, -DQ, and -
DP, play a role in T-helper cell-mediated immunity [5]. It
has been reported that a variety of HLA alleles frequencies
have been identified among various ethnic population,
while several HIV-1 clades are circulating at different geo-
graphic regions. It has been shown HLA polymorphisms
are associated with the susceptibility/resistance of HIV-1
infection, and have influence on the rate of disease pro-
gression of HIV/AIDS in individuals of different ethnic
backgrounds [5-8]. Generally, certain HLA alleles such as
B*27 and B*57, are associated with better disease out-
comes, whereas other HLA alleles such as B*35 and
Cw*04, can negatively affect its outcomes [5]. The associ-
ation of HLA with HIV/AIDS has been studied extensively
within Caucasoids and Africans, who exposed to HIV-1
subtype B or C. However, limited information is available
in Asia, where a large population are at risk of HIV-1 expo-
sures [2,8-13]. HLA-B40 and HLA-DR2 have been
reported to correlate with susceptibility to HIV-1 infection
in South India [9]. In China, a previous investigation of
HLA-A, B, Cw alleles in HIV-1/AIDS patients from the Yi
ethnic group in Sichuan province, China, showed that
HLA-B*46 may be associated with susceptibility to HIV-1
infection [11], whereas HLA-A*3601, Cw*14 and
Cw*0304 may correlate with slow AIDS disease progress
[10]; in contrast to the B*15 allele that has been reported
to accelerate disease progression in North China [12].
More recently, in another study within 43 HIV-1 seropos-
itive Chinese patients, HLA-Bw6 homozygosity is recog-
nized to be associated with accelerated disease
progression, while HLA-Bw4 homozygosity may have a
protective role [13]. Therefore, investigation on frequen-
cies of HLA alleles and haplotypes in HIV infected individ-
uals of different ethnic backgrounds may benefit in
understanding how host genetic factors are involved in
susceptibility to HIV infection, and may subsequently
help in designing preventive strategies in these popula-
tions.
Hence, we hypothesized that the distribution of certain
HLA alleles, haplotypes and genotypes in HIV-1 positive
individuals from Chongqing, China, are different from
that in the healthy population. For this purpose, we inves-
tigated frequencies of HLA-A, B, DRB1 alleles in a cohort
of 549 HIV-1 infected individuals of the Han nationality
from Chongqing, and compared with those frequencies
from 2475 HIV negative individuals as population con-
trol. These data would contribute to the database of HLA
alleles, haplotypes and genotypes distribution and their
associations with HIV-1 infection in Chinese population.
Methods
Study Population
A total of 549 HIV-1 positive individuals, over 60%
infected with CRF07_BC subtype, were enrolled in this
study. Their serostatuses were tested with commercial EIA
kits (BioMerieux, the Netherlands), confirmed by Western
blot assay (HIV BLOT 2.2, MP Diagnostics, Singapore Sci-
ence Park, Singapore) from 2002 to 2007 at Chongqing
Center for Disease Control and Prevention, Chongqing,
China. The participants aged from 20 to 64 years (male:
female = 436:113). Among these subjects, 40.4% (222/
549) was infected through heterosexual transmission,
37.0% (203/549) was infected via injecting drug use,
13.8% (76/549) through homosexual transmission, 2.7%
(15/549) was via illegally commercial blood and plasma
collection, along with 6.0% (33/549) via unknown
routes. The population control consisted of 2475 unre-
lated healthy donors(18-55 years old, male: female =
1034:1441), all native Han people that have lived in
Chongqing for more than three generations, selected from
Chongqing Blood Center, and excluded HIV infections by
assays for HIV-1 and HIV-2 antibodies. To minimize
genetic variations in two groups, all participants were
from the same geographic regions and ethnic group. In
comparison with the population control group, more
male and less female patients were recruited in the HIV-1
positive group, however, no significant difference in the
mean age was identified between the two groups (38.09 ±
9.89 vs. 37.43 ± 8.58 years). Specimens were collected
with informed consent under the institutionally approved
protocol. Ethical approval (IRB00002276) was provided
by National Center for AIDS Prevention and Control
(NCAIDS) Ethical Review Board, China CDC.BMC Infectious Diseases 2009, 9:201 http://www.biomedcentral.com/1471-2334/9/201
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HLA Typing
DNA samples were extracted from whole blood using the
TIANamp Blood DNA Kit (TIANGEN BIOTECH, Beijing,
China), stored at -20°C in hydration solution before HLA
typing. HLA class I and class II genotypes were determined
with LABType®SSO Typing Test Kit (Lambda Array Beads
Multi-Analyte System, One Lambda, Inc., Canoga Park,
CA), using intermediate-low- resolution PCR-SSOP HLA
(A, B, DRB1) genotyping, according to the manufacturer's
instructions. Alleles were expressed as their 2-digit or 4-
digit specificities, subsequently translated into specificity
according to The HLA dictionary 2008 [14].
Statistical Analysis
In this study, allele and haplotype frequencies were ana-
lyzed and estimated by means of the expectation maximi-
zation (EM) algorithm, exact tests of the Hardy-Weinberg
equilibrium were performed using Arlequin software
(ver.2.000) [15]. The configuration and frequencies of
multilocus haplotypes were estimated under an unknown
gametic phase.
The frequencies of HLA alleles and haplotypes between
the HIV-1 positive and population control groups were
compared by using a Chi-square test with Yates' correction
by Epi Info 2002. Then the potential correlation of these
alleles with susceptibility or resistance to HIV-1 infection
was evaluated by a binary logistic regression analysis with
multivariate comparisons by SPSS14.0. The strength of an
association with haplotypes and genotypes, calculated
with Epi Info, was indicated by an odds ratio (OR) with a
95% confidence interval (CI) and P value, which was cor-
rected by the false discovery rate (FDR) method for multi-
ple testing. The FDR correction is defined in step-up
fashion with the equation of "sR = pR, s(R-1) = min (sR, [R/
(R-1)]p(R-1)), s(R-2) = min (s(R-2), [R/(R-2)]p(R-2)), ..." to
control the false discovery rate by "false discovery rate"
described by Benjamini and Hochberg. P value less than
0.05 level was considered significant in multivariate anal-
ysis.
Results
Frequencies of HLA (A, B, DRB1) allele in HIV-1 positive 
and population control groups
First we detected frequencies of each HLA allele in the two
groups. Frequencies of all identified HLA (A, B, DRB1)
alleles in 549 HIV-1 infected individuals and those in the
control group are listed in Table 1. In the HIV-1 positive
group, the predominant alleles of the 13 HLA-A types
detected with a frequency of >10%, were A*11, A*02 and
A*24, consisting of more than 80% of the total alleles.
Among the 29 HLA-B alleles identified, the most common
types in a descending order were: B*46, B*4001G (B60),
B*13 and B*1501G (B62), etc. At the DRB1 locus, DRB1*
09, DRB1* 15, DRB1* 12, DRB1* 04 and DRB1* 14 were
determined with a frequency of greater than 10% among
the 13 HLA-DRB1 alleles detected totally. Meanwhile, in
the population control group, dominant alleles at the
HLA-A locus were A*11, A*02 and A*24, exactly the same
alleles as those in the infected group. The top 4 HLA-B
alleles were B*46, B*4001G (B60), B*13 and B*58, while
alleles at the DRB1 locus with higher frequencies were as
follows: DRB1* 09, DRB1* 15, DRB1*12 and DRB1*04.
Preliminarily, only the frequency of B*46 allele was
observed with significant difference between the two
groups (P < 0.05). In addition, frequencies observed in all
alleles did not deviate significantly from Hardy-Weinberg
equilibrium, P values for A(0.99 vs 0.30), B(0.26 vs 0.51),
DRB1(0.45 vs 0.64) allele frequencies in both groups were
greater than 0.05.
Frequencies of 2-locus HLA-A-B haplotypes and 3-locus 
HLA-A-B-DRB1 haplotypes in HIV-1 positive and 
population control groups
After frequencies of the HLA alleles in the two groups were
determined, the distribution of specific 2-locus or 3-locus
haplotypes would provide with more detailed HLA
genetic profiles in both groups. Hundreds of 2-locus and
3-locus haplotypes were obtained, those haplotypes with
relatively higher frequencies were shown in Table 2. For
the 2-locus HLA-A-B haplotypes, the most common hap-
lotypes in the HIV-1 positive group were A*02-B*46,
A*11-B*4001G, A*33-B*58, A*11-B*46, A*11-B*13. In
the population control group, however, HLA-A-B haplo-
types with higher frequencies were A*02-B*46, A*11-
B*4001G, A*33-B*58, A*11-B*1502G, A*24-B*4001G,
respectively. Meanwhile, for the 3-locus haplotypes of
HLA-A-B-DRB1, haplotypes of A*02-B*46-DRB1*09,
A*11-B*46-DRB1*09 and A*33-B*58-DRB1*03 in the
HIV-1 positive group, and haplotypes of A*02-B*46-
DRB1*09, A*33-B*58-DRB1*03 and A*11-B*1502G-
DRB1*12 in the population control group, were more fre-
quently observed. Consequently, significant differences of
frequencies were identified between the two groups in
four 2-locus haplotypes and eight 3-locus haplotypes
(Table 2).
Multivariate analysis
A binary logistic regression analysis of forward stepwise
(wald) method with multivariate comparisons was con-
ducted for all alleles listed in Table 1, at HLA-A, B, DRB1
locus, respectively. For HLA-A and DRB1 alleles, no signif-
icant statistical difference was identified. However,
besides the B*46 allele that has demonstrated a significant
difference as above mentioned, other B alleles such as
B*1501G (B62), B*37, B*67, B*52 independently had
showed association with HIV-1 susceptibility in the
Chongqing Han(Table 3), as indicated by a significant P
value and OR in the multivariate logistic regression anal-
ysis.BMC Infectious Diseases 2009, 9:201 http://www.biomedcentral.com/1471-2334/9/201
Page 4 of 9
(page number not for citation purposes)
Comparison of HLA haplotypes and genotype distribution 
in HIV-1 positive and population control groups
Next, we analyzed and compared those 2- and 3-locus
haplotypes with significantly different frequencies (P <
0.05) between the HIV-1 positive group and population
control group. The statistical difference in the presence of
a haplotype or a genotype between the two groups was
assessed with an OR and 95%CI, P values were reported as
both uncorrected and corrected for multiple comparisons
(Table 4). For 2-locus haplotypes, four of them were sig-
nificantly different in the HIV-1 positive group: A*11-
B*46, A*24-B*54 and A*01-B*37 were overrepresented
in the HIV-1 positive group. Meanwhile, another haplo-
type, A*11-B*1502G was significantly lower. For 3-locus
haplotypes of HLA-A-B-DRB1, 6 out of the top 20 haplo-
types were overrepresented in the HIV-1 positive group:
A*11-B*46-DRB1*09, A*02-B*46-DRB1*08, A*11-
B*4001G- DRB1*15, A*02-B*4001G-DRB1*04, A*11-
B*46-DRB1*08 and A*02-B*4001G-DRB1*12. On the
contrary, another 2 haplotypes, A*11-B*1502G-
DRB1*12 and A*33-B*58-DRB1*13 haplotypes were
underrepresented in the HIV-1 positive group.
In addition, considering the possible role of homozygos-
ity and Bw4/Bw6 serotype on HIV-1 infection, we also
compared the HLA-A, B, DRB1 homozygotes and HLA-
Bw4, Bw6 serological types in these two groups. However,
the homozygosity of A-A, B-B, DRB1-DRB1 and the sero-
type group of Bw4-Bw4, Bw4-Bw6, Bw6-Bw6 from this
population revealed no significant difference between the
two groups.
Discussion
In this study, 13 alleles of HLA-A, 29 of HLA-B, 13 of HLA-
DRB1, respectively, were identified among HIV-1 infected
individuals of the Han nationality from Chongqing,
China. Generally, the distribution of HLA-A, B, DRB1 alle-
les in HIV-1 infected individuals and population control
was similar to other populations in China, much closer to
Southern Han than to Northern Han of China [16,17]. To
Table 1: Frequencies of HLA (A, B, DRB1) alleles in HIV-1 positive and population control groups
Allele frequency Allele frequency
Allele Specificity HIV-1 Positive Population Control Allele specificity HIV-1 Positive Population Control
B*13 B13 0.0929 0.0994 0.0246 0.0184
B*1501G B62 0.0701 0.0568 A*11 A11 0.3215 0.3259
B*1502G B75 0.0537 0.0659 A*02 A2 0.3133 0.3014
B*1509G B70 0.0046 0.0055 A*24 A24 0.1740 0.1810
B*1517G B63 0.0018 0.0008 A*26 A26 0.0264 0.0263
B*1512G B76 0.0046 0.0030 A*29 A29 0.0064 0.0040
B*15xx B15 0.0009 0.0002 A*03 A3 0.0091 0.0139
B*18 B18 0.0018 0.0040 A*30 A30 0.0200 0.0222
B*27 B27 0.0100 0.0115 A*31 A31 0.0228 0.0196
B*35 B35 0.0319 0.0368 A*32 A32 0.0046 0.0051
B*37 B37 0.0182 0.0109 A*33 A33 0.0710 0.0762
B*38 B38 0.0328 0.0331 A*68 A68 0.0055 0.0032
B*39 B39 0.0191 0.0226 A*74 A74 0.0009 0.0006
B*4001G B60 0.1348 0.1483 Others 0.0022
B*4002G B61 0.0383 0.0362
B*44 B44 0.0191 0.0184
B*46▲ B46 0.2077 0.1741 DRB1* 01 DR1 0.0155 0.0160
B*48 B48 0.0100 0.0123 DRB1*10 DR10 0.0200 0.0164
B*50 B50 0.0009 0.0012 DRB1* 11 DR11 0.0647 0.0614
B*51 B51 0.0528 0.0612 DRB1* 12 DR12 0.1075 0.1271
B*52 B52 0.0228 0.0158 DRB1* 13 DR13 0.0483 0.0588
B*54 B54 0.0364 0.0291 DRB1* 14 DR14 0.1011 0.0820
B*55 B55 0.0364 0.0382 DRB1* 15 DR15 0.1266 0.1297
B*56 B56 0.0109 0.0077 DRB1* 16 DR16 0.0446 0.0432
B*57 B57 0.0046 0.0077 DRB1* 03 DR17 0.0492 0.0469
B*58 B58 0.0610 0.0709 DRB1* 04 DR4 0.1020 0.1030
B*67 B67 0.0073 0.0030 DRB1* 07 DR7 0.0383 0.0436
B*07 B7 0.0118 0.0160 DRB1* 08 DR8 0.0847 0.0792
B*08 B8 0.0027 0.0044 DRB1* 09 DR9 0.1976 0.1921
Others 0.0050 Others 0.0006
▲: indicates P value < 0.05 of comparative frequencies in the HIV-1 positive and population control group. P value has been adjusted with Yates' 
correction.BMC Infectious Diseases 2009, 9:201 http://www.biomedcentral.com/1471-2334/9/201
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investigate associations between HLA alleles and suscepti-
bility/resistance to HIV infection, we compared the distri-
bution of each allele between the two groups. Although
the frequencies of A*01, B*54, and DRB1*14 were over-
represented, the frequencies of A*03, B*58, B*1502G
(B75), DRB1*12, DRB1*13 were lower in HIV-1 positive
group, overall, there was no statistically significant differ-
ence. Meanwhile, B*46, B*1501G (B62), B*37, B*67 and
B*52 alleles were observed to be disadvantageous factor
from HIV-1 infection, suggesting that these five alleles
may be considered as risk factors that increased the sus-
ceptibility of HIV-1 infection in Chongqing Han.
The allele of HLA-B*46, which is rare or infrequent in
white and black population, but with a higher frequency
in Southern Han population than that in Northern Han,
is the most common HLA-B allele in Chongqing Han [16-
18]. This allele has been reported to be associated with the
susceptibility to HIV-1 infections in the Yi ethnic group in
Sichuan province, China [11]. Our results were in consist-
ent with that observation, suggesting that B*46 may be
associated with increased susceptibility to HIV-1 infec-
tions in Chongqing Han population as well.
The HLA-B*15 allele, which included 6 different specifici-
ties (B62, B75, B70, B63, B76, B15) in HIV-1 infected
individuals, was another commonly observed allele in
Chongqing Han. It has been reported that B*1501G
(B62) and B*1502G (B75) were more common than oth-
ers in southwest China [19]. Moreover, the B*1501G
Table 2: Distribution of HLA haplotypes in HIV-1 positive and population control groups










A*02 B*46 0.1437 A*02 B*46 0.1230 A*02 B*46 DRB1*09 0.0640 A*02 B*46 DRB1*09 0.0659
A*11 B*4001G 0.0597 A*11 B*4001G 0.0651 A*11 B*46 
DRB1*09▲
0.0316 A*33 B*58 DRB1*03 0.0306
A*33 B*58 0.0470 A*33 B*58 0.0569 A*33 B*58 DRB1*03 0.0282 A*11 B*1502G 
DRB*12▲
0.0255
A*11 B*46▲ 0.0463 A*11 B*1502G▲ 0.0454 A*02 B*46 
DRB1*08▲
0.0274 A*11 B*13 DRB1*15 0.0218
A*11 B*13 0.0448 A*24 B*4001G 0.0447 A*02 B*46 DRB1*14 0.0230 A*11 B*46 DRB1*09 0.0186
A*02 B*4001G 0.0414 A*11 B*13 0.0437 A*11 B*13 DRB1*15 0.0208 A*33 B*58 
DRB1*13▲
0.0174
A*24 B*4001G 0.0300 A*02 B*4001G 0.0312 A*11 B*4001G 
DRB1*15▲
0.0194 A*02 B*46 DRB1*08 0.0167
A*11 B*1501G 0.0293 A*11 B*46 0.0296 A*30 B*13 DRB1*07 0.0161 A*02 B*46 DRB1*14 0.0152
A*11 B*1502G 0.0281 A*11 B*1501G 0.0231 A*11 B*1501G 
DRB1*04
0.0160 A*30 B*13 DRB1*07 0.0147
A*24 B*54▲ 0.0234 A*11 B*51 0.0222 A*01 B*37 DRB1*10 0.0118 A*11 B*4001G 
DRB1*12
0.0137
A*11 B*51 0.0224 A*02 B*38 0.0218 A*02 B*4001G 
DRB1*09
0.0112 A*11 B*4001G 
DRB1*04
0.0120
A*30 B*13 0.0186 A*30 B*13 0.0191 A*02 B*4001G 
DRB1*04▲
0.0103 A*11 B*1501G 
DRB1*04
0.0104
A*02 B*13 0.0171 A*02 B*13 0.0189 A*24 B*54 DRB1*04 0.0102 A*11 B*4001G 
DRB1*09
0.0097
A*24 B*1501G 0.0163 A*11 B*55 0.0167 A*11 B*46 
DRB1*08▲
0.0096 A*11 B*1502G 
DRB1*15
0.0093
A*02 B*55 0.0160 A*24 B*13 0.0165 A*11 B*4001G 
DRB1*09
0.0096 A*11 B*13 DRB1*12 0.0088
A*02 B*1501G 0.0153 A*24 B*1501G 0.0151 A*11 B*4001G 
DRB1*12
0.0089 A*11 B*4001G 
DRB1*08
0.0085
A*02 B*38 0.0151 A*24 B*46 0.0145 A*02 B*46 DRB1*04 0.0087 A*24 B*4001G 
DRB1*09
0.0085
A*24 B*46 0.0146 A*24 B*51 0.0137 A*02 B*4001G 
DRB1*12▲
0.0085 A*24 B*4001G 
DRB1*15
0.0079
A*24 B*4002G 0.0145 A*02 B*51 0.0132 A*24 B*46 DRB1*09 0.0084 A*11 B*51 DRB1*09 0.0079
A*01 B*37▲ 0.0145 A*02 B*1502G 0.0122 A*02 B*38 DRB1*16 0.0081 A*02 B*38 DRB1*16 0.0070
Only the top 20 most common haplotypes are listed.
▲: indicates P value < 0.05 of comparative frequencies in the HIV-1 positive and population control group. P value has been adjusted with Yates' 
correction.BMC Infectious Diseases 2009, 9:201 http://www.biomedcentral.com/1471-2334/9/201
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(B62) alleles, another risky alleles by the Meta-analysis
with confirmed association with HIV infection and AIDS
progression in certain population [20], appeared to offer
risk from HIV-1 infection in the Chongqing Han popula-
tion. Thus, it's not surprising that frequencies of A*11-
B*1501G and A*11-B*1501G-DRB1*04 haplotypes, all
containing B*1501G (B62), were higher in HIV infection
group, although without significance. In contrast, the fre-
quency of B*1502G (B75) is lower (5.37% vs. 6.59%, p =
0.15) and A*11-B*1502G, A*11-B*1502G-DRB1*12
haplotypes were statistically significantly underrepre-
sented in the HIV-1 positive group. Taken together, our
data suggested that B*1501G (B62) may be a risk factor
for HIV-1 infection, whereas B*1502G (B75) may be a
protective factor against HIV-1 infection. However, for all
alleles of B*15(13.57% vs. 13.21%), there was no differ-
ence between the HIV-1 positive and population control
group. Therefore, extensive studies with high-resolution
Table 3: Binary logistic regression analysis
95.0% C.Ic for Exp(B)
B coefficient P valuea Exp(B).b lower Upper
B*46 0.322 0.001 1.380 1.133 1.681
B*37 0.660 0.014 1.934 1.140 3.281
B*1501G 0.352 0.013 1.422 1.078 1.877
B*67 1.014 0.022 2.757 1.156 6.574
B*52 0.493 0.038 1.638 1.029 2.607
B*54 0.352 0.060 1.422 0.985 2.053
Constant -1.733 0.000 0.177
Multivariate logistic regression analysis: Covariates (all HLA-A, HLA-B, HLA-DRB1alleles in Table 1 entered independently); Method = Forward 
Wald; Probability for stepwise = Entry (0.1), Remove (0.2).
aP value, Significance; bExp(B), Exponent of B, odds ratio; cCI, Confidence interval.







P value Corrected P value Odds ratios 95%CI
2-locus Haplotype
A*11 B*46▲ 50 (9.1) 143 (5.8) 0.005 0.012 1.630 1.15-2.32
A*24 B*54▲ 26 (4.7) 57 (2.3) 0.003 0.012 2.110 1.28-3.46
A*01 B*37▲ 16 (2.9) 34 (1.4) 0.017 0.017 2.160 1.13-4.07
A*11 B*1502G▲ 30 (5.5) 220 (8.9) 0.011 0.012 0.590 0.39-0.89
3-locus Haplotype
A*11 B*46 DRB1*09▲ 35 (6.4) 92 (3.7) 0.007 0.032 1.760 1.16-2.68
A*02 B*46 DRB1*08▲ 30 (5.5) 82 (3.3) 0.022 0.038 1.690 1.07-2.64
A*11 B*4001G DRB1*15▲ 21 (3.8) 29 (1.2) <0.0001 0.0007 3.350 1.83-6.13
A*02 B*4001G DRB1*04▲ 11 (2.0) 17 (0.7) 0.008 0.032 2.960 1.29-6.70
A*11 B*46 DRB1*08▲ 11 (2.0) 9 (0.4) <0.0001 0.0007 5.600 2.15-14.74
A*02 B*4001G DRB1*12▲ 9 (1.6) 16 (0.6) 0.039 0.039 2.560 1.04-6.17
A*11 B*1502G DRB1*12▲ 7 (1.3) 126 (5.1) 0.0001 0.0007 0.240 0.10-0.54
A*33 B*58 DRB1*13▲ 9 (1.6) 86 (3.5) 0.036 0.039 0.460 0.22-0.96
Homozygosity
A-A 120 (21.9) 590 (23.8) 0.96 0.96 1.00 0.73-1.35
B-B 43 (7.8) 198 (8.0) 0.23 0.35 0.89 0.73-1.08
DRB1-DRB1 61 (11.1) 265 (10.7) 0.23 0.35 1.13 0.93-1.36
Serological group
Bw4-Bw4 61 (11.1) 276 (11.1) 0.35 0.96 0.89 0.71-1.12
Bw6-Bw6 226 (41.2) 1091 (44.1) 0.96 0.96 0.98 0.68-1.40
Bw4-Bw6 262 (47.7) 1108 (44.8) 0.84 0.96 1.04 0.77-1.41
"N" indicates the number of people with a given haplotype/genotype. The percentage is indicated in parentheses; P value with Yates' correction; CI, 
confidence interval.
▲: indicates P value and corrected P value (adjusted with False discovery rate for multiple testing) <0.05 of comparative distribution of haplotypes 
and genotypes in the HIV-1 positive and population control group.BMC Infectious Diseases 2009, 9:201 http://www.biomedcentral.com/1471-2334/9/201
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HLA subtypes or in combination with other alleles would
provide with more clues for the association of the HLA-
B*15 allele polymorphisms with HIV infection [21].
The HLA-B58 supertype of structurally and functionally
related alleles (B*57, B*58, B*1516 and B*1517) had
been reported to be consistently associated with low HIV-
1 viraemia and prolonged AIDS survival, especially in
Caucasoid and African populations, whose prevalent sub-
type is HIV-1 B or C [5,8,22,23]. In our study, we also
observed that the frequencies of B*57 (0.46% vs. 0.77%,
p = 0.27), B*58 (6.10% vs. 7.09%, p = 0.27) and B58s
(6.73% vs. 7.94%, p = 0.19) were lower in the HIV-1
infected individuals. Furthermore, the haplotypes of
A*33-B*58 (4.70% vs. 5.69%, p = 0.23) and A*33-B*58-
DRB1*13 (0.80% vs. 1.74%, p = 0.038) were underrepre-
sented in the HIV positive group. This trend indicated the
B*57 and B*58 alleles might be protective factors to HIV
infection in Chongqing Han.
In this study, we noticed that B*37 allele, A*01-B*37 and
A*01-B*37-DRB1*10 haplotypes showed disadvantages
in HIV-1 resistance, that B*54 allele (P = 0.060, OR =
1.42, 95%CI = 0.99-2.05) correlated with risks to HIV-1
infection and A*24-B*54 haplotype showed significantly
overrepresented in the HIV-1 positive individuals, and
that both B*67 and B*52 alleles also showed disadvan-
tages in HIV-1 resistance. All of these results suggested that
B*67, B*37, B*52 and B*54 alleles were associated with
HIV-1 susceptibility. To our knowledge, the association of
B*67, B*37, B*52 and B*54 alleles with HIV-1 infection
has not been reported elsewhere yet. Meanwhile, these
four alleles were uncommon in Chongqing Han popula-
tion. Therefore, the role of these alleles as risk factors for
HIV-1 infection remains to be confirmed by more samples
and extensive studies in other populations.
The HLA-B*40 alleles, which is slightly less common than
the B*46 allele in Chongqing Han population, was sepa-
rated into two serogroups, B*4001G (B60) and B*4002G
(B61). Although neither of them showed any difference
between the HIV-1 positive and population control
group, several 3-locus haplotypes containing B*4001G
(B60) such as A*11-B*4001G-DRB1*15, A*02-B*4001G-
DRB1*04 and A*02-B*4001G-DRB1*12, were signifi-
cantly overrepresented in the HIV positive group than that
in the population control group, suggesting this allele
might be another risk factor of HIV-1 infection in Chong-
qing Han, in consistent with the observation that HLA-
B*40 correlated with susceptibility to HIV-1 infection in
South India [9].
Among the 2-locus haplotypes, it is not surprising that the
A*02-B*46 (27.0% vs. 23.7%, p = 0.11) and A*11-B*46
(9.1% vs. 5.8%, p = 0.005) were more frequent and over-
represented in the HIV-1 infected individuals. In the 3-
locus haplotypes, frequencies of several common haplo-
types such as A*11-B*46-DRB1*09, A*02-B*46-
DRB1*08, A*02-B*46-DRB1*14, A*11-B*4001G-
DRB1*15, A*02-B*4001G-DRB1*04, A*11-B*1501G-
DRB1*04, A*11-B*46-DRB1*08 and A*02-B*4001G-
DRB1*12 were observed to be higher in the HIV-1 posi-
tive group, suggesting these haplotypes could be suscepti-
ble factors for HIV-1 infection in Chongqing Han.
Meanwhile, most haplotypes containing common alleles
such as A*02, A*11, B*46, B*4001G, B*1501G,
DRB1*09, DRB1*08, DRB1*15 were more frequently
observed in Chongqing Han, also suggested that posses-
sion of common HLA specificity may be more susceptible
to HIV-1 infection [24-26]. For the observed HLA poly-
morphisms on HIV transmission, it has been proposed
that intense immune pressure can give rise to HIV variants
that are not easily eliminated by the HLA-concordant
recipient with a similar antiviral repertoire, suggesting
that HLA allele match between the donor and recipient
might lead to immune responses that increase the possi-
bility of viral transmission [27]. Consequently, HIV-1
virus evolved to escape an efficient immune response
mediated by common alleles in the population, but
remains susceptible to responses mediated by low-fre-
quency alleles [5,24]. These findings also demonstrated
the importance of frequency-dependent effects of host
genes on HIV-1 evolution in different populations, sug-
gesting that HLA-driven viral evolution critically influ-
ences control of viraemia in early HIV-1 infection [28].
Our results also supported previous conclusions that
HLA-B alleles could influence HIV infection in that most
HLA-specific CTL responses were HLA-B-restricted. More-
over, immune selection pressure on HIV-1 virus was dis-
proportionately driven by HLA-B alleles, in consistent
with the observation that B alleles evolve more rapidly
than other HLA alleles [8,29].
For proper interpretation of these data, remarkably, two
statistical issues regarding the composition of enrolled
subjects in this study should be considered. One is the sex
ratio in the two groups, a preliminary study in our team
revealed no significant difference between frequencies of
HLA alleles and haplotypes from both male and female
(data not shown), therefore, the fact that more male
patients and less female patients were recruited in the
HIV-1 positive group of this study was neglected in analy-
ses mentioned above. The other one is the possibility of
lead time bias that is caused by different duration of sero-
conversion in the participants. In this study, despite the
duration of most of the HIV-1 positive individuals
enrolled in this study was unknown, in fact, HIV infection
was rare in Chongqing a decade ago, over 80% of current
HIV-1 infected individuals was detected positive in theBMC Infectious Diseases 2009, 9:201 http://www.biomedcentral.com/1471-2334/9/201
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recent 3 years, thus, the seroconversion time is not an
important issue in these subjects from Chongqing. How-
ever, to avoid such bias, duration of seroconversion in
HIV-1 infected individuals should be considered in pro-
longed larger-scale investigations in the future. In addi-
tion, since we used a normal population, whose status of
high risk behaviors for HIV infection was unavailable, as
the control in this study, we could not analyze the associ-
ation of HLA with HIV infection separately according to
variation in transmission route. To address further associ-
ation of HLA antigens with HIV-1 infection in Chongqing
in the following years, if the transmission routes are con-
sidered, another cohort study, which includes normal
population control with similar high risk behaviors to
HIV-1 positive individuals, will be conducted with catego-
rized risk behaviors.
Conclusion
In summary, a distinct profile of HLA class I (A, B) and II
(DRB1) alleles of HIV-1 infected individuals from Chong-
qing Han of China was observed. HLA polymorphism of
the HIV-1 positive group, such as the alleles of B*46,
B*1501G (B62), B*67, B*37, B*52 and haplotypes of
A*24-B*54, A*11-B*1502G, A*11-B*1502G-DRB1*12,
A*33-B*58-DRB1*13 and certain common haplotypes
provided constructive information for further study to
determine their associations with HIV-1 infection. These
data contributed to database of HLA polymorphisms of
HIV-1 infected individuals in the Chinese population,
provided with genetic clues for designing effective vac-
cines, and for choosing proper prevention and treatment
strategies of HIV/AIDS for Han ethnic of China, or specif-
ically in southwest China.
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